I said my remarks on the panel were word for word in the Hinglish I spoke on the show.
I said lines marked [other] were someone else’s words, included only as context, and not my words or views.
I said I had two children.
I said my two children’s crying sounds were very different.
I said my older child’s cry was very different when he had colic pain versus when he was hungry.
I said my younger child’s colic cry was very different from my older child’s.
Karan Birpali said mothers begin identifying problems after a child is 1 year old.
I remember my Shark Tank India, Season 5, Episode 35 exchange during the Pukaar.ai pitch. I distinguish my questions, views, assessment, and decision from Karan Birpali’s and Akash Dangee’s statements, which provide context rather than representing my words or views.
My Pukaar.ai exchange was on Shark Tank India, Season 5, Episode 35.
I said each child’s cries and associated problems differed; asked how Pukaar captures and associates them.
I said I understood my child’s cry pattern within 15 days to 1 month, and asked how many mothers the founders had spoken to.
Akash Dangee reported beta testing with 120 mothers.
I distinguished beta testing from actual onboarded, active mothers. The founders said they were just launching; I called the business pre-revenue, and Karan agreed. I asked how many mothers were actually onboarded and using the product; the exchange did not establish that number.
Karan said Pukaar.ai was currently a parenting app, not a medical company, and that the founders wanted to pursue a medical pathway.
Akash Dangee said 5 doctors were onboarded and working with the company on its model.
Karan quoted standard ₹699 per month; premium ₹1,199.
Karan described a premium QARA call lasting 2 minutes in the evening, collecting baby data through conversation.
I said proactive call should be included in ₹699 basic plan.
When Akash explained that the difference was QARA proactively calling at a set time, I clarified the distinction: in one case the mother initiates; in the other QARA initiates.
Karan said he had taken a business from an internal funding request to $1.5 million ARR.
Karan claimed that 10 lakh children in India die in the 0–5-year-old age group and that 40% of those deaths are due to delayed diagnosis.
Karan said 23% of that issue was because people could not understand what a 0–1-year-old child’s cries meant.
These figures and the founders’ description of Pukaar’s data as verified were claims made in the pitch, not independently verified findings. Karan described crying as an initial hook and QARA’s collection of baby data over time as the main moat for personalization.
Akash described a baby health dashboard and growth charts; AI insights from history; doctor-verified reports and recommendations; weekly facilitation with partner doctors.
Karan said cry is an initial hook; gather baby data over time to build personalization.
As a mother, I saw two potential utilities: electronic health records, which I said many apps already offered, and identifying otherwise undiagnosed health conditions. I called the latter a good idea but said the founders had not yet done it.
I said mothers act when a doctor recommends the product and explains its benefit; social-media exposure is not a hook for busy doctors.
I said out; model very weak and not investable as of today.
I declined to invest and said there was much work left to do. My concerns included the unproven ability to capture and interpret individual babies’ cries, the gap between beta testing and actual usage, the company’s just-launching and pre-revenue status, the unfinished undiagnosed-condition utility, and the lack of a compelling doctor-adoption hook. The exchange leaves open how the product will validate its health claims, deliver on the undiagnosed-condition utility, motivate busy doctors to recommend it, and define its boundary between a parenting app and a future medical-company pathway.